Jasper Therapeutics's market cap is currently $89.86M. The company's EPS TTM is $-4.746; its P/E ratio is ―; Jasper Therapeutics is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $-1.25. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -1.11M	$ -1.31M	$ -566.00K	$ -21.00K	$ 0.00
Operating Income	$ -68.86M	$ -51.20M	$ -36.83M	$ -20.68M	$ -4.71M
EBITDA	$ -64.98M	$ -38.21M	$ -31.17M	$ -31.95M	$ -277.00K
Net Income	$ -64.47M	$ -24.17M	$ -23.98M	$ -31.67M	$ -4.99M
Balance Sheet
Cash & Short-Term Investments	$ 86.89M	$ 38.25M	$ 84.70M	$ 19.84M	$ 27.16M
Total Assets	$ 94.89M	$ 48.36M	$ 93.65M	$ 23.36M	$ 27.21M
Total Debt	$ 2.79M	$ 3.65M	$ 2.88M	$ 1.62M	$ 0.00
Net Debt	$ -84.10M	$ -34.60M	$ -81.82M	$ -18.21M	$ -27.16M
Total Liabilities	$ 16.45M	$ 12.37M	$ 24.14M	$ 58.49M	$ 1.99M
Stockholders' Equity	$ 78.44M	$ 35.99M	$ 69.52M	$ -35.13M	$ 21.10M
Cash Flow
Free Cash Flow	$ -52.33M	$ -46.43M	$ -36.11M	$ -18.27M	$ -1.97M
Operating Cash Flow	$ -52.07M	$ -45.86M	$ -33.68M	$ -18.27M	$ -1.97M
Investing Cash Flow	$ -267.00K	$ -576.00K	$ -2.43M	$ 198.34K	$ 0.00
Financing Cash Flow	$ 100.97M	$ 55.00K	$ 100.97M	$ 11.29M	$ 29.13M

Currency in USD

Jasper Therapeutics Earnings and Revenue History

Income Statement >

Jasper Therapeutics Debt to Assets

Balance Sheet >

Jasper Therapeutics Cash Flow

Cash Flow >

Jasper Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing